New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
09:17 EDTWCG, CRNT, ACRX, TRLA, DLTR, SOHU, TSN, CVS, CACI, Z, FDO, FSLR, ACW, HZNP, XGTI, DGOn The Fly: Pre-market Movers
HIGHER: Family Dollar (FDO), up 23% after Dollar Tree (DLTR) announced plans to acquire the company for $74.50 per share in cash and stock. Dollar Tree up 10% after the news, while competitor Dollar General (DG) is down 3.8% in pre-market trading after the deal... Trulia (TRLA), up 11.8% after Zillow (Z) announced plans to acquire the company for $3.5B in a stock-for-stock deal. Zillow is down 5% after confirming the deal that was first reported to be in the works late last week... xG Technology (XGTI), up 16.6% after awarded U.S. Army subcontract by CACI (CACI)... WellCare (WCG), up 2.6% after upgraded at Goldman and Sterne Agee... First Solar (FSLR), up 2.7% after establishing a supply agreement in Japan with XSOL. UP AFTER EARNINGS: Accuride (ACW), up 12.7%... Tyson Foods (TSN), up 4.4%. LOWER: AcelRx (ACRX), down 35% after downgraded at Canaccord following the FDA's request for additional data on the Zalviso system... Horizon Pharma (HZNP), down 26% after said it has been notified that Duexis, Vimovo to be placed on CVS (CVS) and Express Scripts' (ESRX) exclusion lists... DOWN AFTER EARNINGS: Sohu.com (SOHU), down 4.2%... Ceragon Networks (CRNT), down 8%.
News For FDO;DLTR;DG;Z;TRLA;XGTI;CACI;ACRX;HZNP;CVS;CRNT;ACW;TSN;WCG;FSLR;SOHU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 17, 2014
09:26 EDTTSNTyson says demand for beef 'very strong'
Subscribe for More Information
09:22 EDTTSNTyson Foods trades higher after earnings, levels to watch
Subscribe for More Information
09:22 EDTTSNOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTDGDollar General says now accepting American Express cards
Subscribe for More Information
07:35 EDTTSNTyson Foods sees Hillshire acquisition adding $4B in revenues in FY15
The company says "We expect to realize substantial synergies from combining our Prepared Foods business with Hillshire Brands. Synergies are expected to come primarily from operational improvements, purchasing and distribution. As we execute our Prepared Foods strategy, we estimate the impact of the Hillshire Brands synergies, along with the cost savings and the production efficiencies associated with the previously announced plant closures, will positively impact our Prepared Foods segment by more than $225 million in fiscal 2015, and more than $500 million by the third full year of ownership. As we continue to integrate these businesses and deliver the first year synergies, the near-term results for fiscal 2015 are expected to be above the top end of our prior range of 6% despite a projected increase in raw material costs. However, as a result of the improvements we have made in our Prepared Foods business, our acquisition of Hillshire Brands and the significant synergies we expect to realize over the next few years, we believe the long-term profitability of this business should be between 10-12%."
07:35 EDTTSNTyson Foods sees FY15 sales $42B, consensus $42.51B
Subscribe for More Information
07:33 EDTTSNTyson Foods sees FY15 adjusted EPS $3.30-$3.40, consensus $3.33
Subscribe for More Information
07:32 EDTTSNTyson Foods reports Q4 adjusted EPS 87c, consensus 76c
Reports Q4 revenue $10.11B, consensus $10.16B.
07:05 EDTXGTIxG Technology reports order from Airogistic for xMax cognitive radio
xG Technology has received an order from Airogistic, an Austin, TX-based OEM of UAV infrastructure solutions. The order covers the sale of xMax cognitive radio networking equipment that Airogistic will adapt for use in infrastructure destined for the commercial UAV market. As part of the agreement, xG will provide assistance to Airogistic in its ongoing research and development efforts in this market as it pertains to the integration of xG's technology.
November 14, 2014
17:27 EDTFDOPaulson & Co. gives quarterly update on stakes
Subscribe for More Information
14:53 EDTCVSCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
08:06 EDTHZNPHorizon Pharma 11.66M share Secondary priced at $12.05
Subscribe for More Information
November 13, 2014
16:40 EDTWCGPennant Capital reports 7.0% passive stake in WellCare
14:56 EDTHZNPHorizon Pharma says Watson Labs filed ANDA for generic PENNSAID
Subscribe for More Information
10:44 EDTFSLROptions with decreasing implied volatility
Subscribe for More Information
10:01 EDTTSNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:38 EDTZBloomberg Link to hold a conference
The Year Ahead: 2015 is being held in Washington, D.C. with a pre-conference dinner on November 13 followed by company presentations on November 14,
07:08 EDTACRXAcelRx to present positive efficacy results in Phase 3 trial of Zalviso
AcelRx Pharmaceuticals will present safety and efficacy data from a Phase 3 pivotal trial evaluating the Zalviso sufentanil sublingual tablet system for the treatment of moderate-to-severe acute pain following joint replacement surgery at the American Society of Regional Anesthesia and Pain Medicine 13th Annual Pain Medicine Meeting on November 13th to November 16th in San Francisco. Data from the sublingual sufentanil tablet system development program highlights efficacy across various demographic populations
07:06 EDTHZNPHorizon Pharma files to sell 11.66M shares for existing holders
Horizon Pharma announced a proposed underwritten secondary offering of 11.66M of its ordinary shares held by certain of its existing shareholders. Morgan Stanley, Citigroup, Cowen and Jefferies are acting as joint book-running managers for this offering. JMP Securities is acting as financial advisor for this offering.
06:44 EDTTSNTyson Foods initiated with an Outperform at RBC Capital
Target $48.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use